title: Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract.
abstract: Chicory is a major source of fructans with reported prebiotic-bifidogenic properties. In the present study, the potential anti-inflammatory activities of chicory were investigated. Ethyl acetate chicory root extract produced a marked inhibition of prostaglandin E(2) (PGE(2)) production in human colon carcinoma HT29 cells treated with the pro-inflammatory agent TNF-alpha. Two independent mechanisms of action were identified: (1) a drastic inhibition of the induction by TNF-alpha of cyclooxygenase 2 (COX-2) protein expression and (2) a direct inhibition of COX enzyme activities with a significantly higher selectivity for COX-2 activity. The inhibition of TNF-alpha-dependent induction of COX-2 expression was mediated by an inhibition of NF-kappaB activation. A major sesquiterpene lactone of chicory root, the guaianolide 8-deoxylactucin, was identified as the key inhibitor of COX-2 protein expression present in chicory extract. Altogether, the data presented strongly support chicory root as a promising source of functional food ingredient, combining prebiotic and anti-inflammatory properties.
authors.affiliation: Quality and Safety Department, Nestlé Research Center, P.O. Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland. Christophe.Cavin@rdls.nestle.com
authors.forename: C
authors.initials: C
authors.lastname: Cavin
authors.forename: M
authors.initials: M
authors.lastname: Delannoy
authors.forename: A
authors.initials: A
authors.lastname: Malnoe
authors.forename: E
authors.initials: E
authors.lastname: Debefve
authors.forename: A
authors.initials: A
authors.lastname: Touché
authors.forename: D
authors.initials: D
authors.lastname: Courtois
authors.forename: B
authors.initials: B
authors.lastname: Schilter
mesh_terms: D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D018651:Cichorium intybus / Q000737:chemistry*; D051546:Cyclooxygenase 2; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D019073:HT29 Cells / Q000187:drug effects; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000378:metabolism*; D007783:Lactones / Q000737:chemistry / Q000494:pharmacology; D008565:Membrane Proteins; D016328:NF-kappa B / Q000378:metabolism; D010936:Plant Extracts / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism*; D012717:Sesquiterpenes / Q000737:chemistry / Q000494:pharmacology; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D000893:Anti-Inflammatory Agents; D004791:Enzyme Inhibitors; D007783:Lactones; D008565:Membrane Proteins; D016328:NF-kappa B; D010936:Plant Extracts; D012717:Sesquiterpenes; D014409:Tumor Necrosis Factor-alpha; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases